Literature DB >> 15331528

Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain.

Manfred Hallschmid1, Bernd Schultes, Lisa Marshall, Matthias Mölle, Werner Kern, Julia Bredthauer, Horst L Fehm, Jan Born.   

Abstract

Circulating insulin is thought to provide a major feedback signal for the hypothalamic regulation of energy homeostasis and food intake, although this signaling appears to be slowed by a time-consuming blood-to-brain transport. Here we show, by recording direct current potentials, a rapid onset of the effects of circulating insulin on human brain activity. Recordings were obtained from 27 men who were intravenously injected with insulin (0.1 mU/kg body wt as bolus) and placebo. In a euglycemic condition, hypoglycemia was prevented, while in the hypoglycemic condition, plasma glucose reached a postinjection nadir of 43 mg/dl. Insulin injection induced a marked negative direct current (DC) potential shift starting within 7 min in all subjects. With euglycemic conditions, the DC potential at 10-60 min postinsulin injection averaged -621.3 microV (compared with preinjection baseline). Hypoglycemia reduced this potential to an average of -331.2 microV. While insulin per se did not affect oscillatory electroencephalographic activity, hypoglycemia peaking 25 min after insulin injection was accompanied by an immediate increase in theta activity. The rapid emergence of the DC potential shift, reflecting gross ionic changes in brain tissues, indicates that systemic insulin can serve as an immediate feedback signal in the control of hypothalamic and higher brain functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331528     DOI: 10.2337/diabetes.53.9.2202

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study.

Authors:  Otto Tschritter; Hubert Preissl; Anita M Hennige; Michael Stumvoll; Katarina Porubska; Rebekka Frost; Hannah Marx; Benjamin Klösel; Werner Lutzenberger; Niels Birbaumer; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

Review 2.  Impaired insulin action in the human brain: causes and metabolic consequences.

Authors:  Martin Heni; Stephanie Kullmann; Hubert Preissl; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

Review 3.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

4.  Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

Authors:  M Hallschmid; B Schultes
Journal:  Diabetologia       Date:  2009-08-25       Impact factor: 10.122

Review 5.  [Targeting the brain through the nose. Effects of intranasally administered insulin].

Authors:  Y F Brünner; C Benedict; J Freiherr
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

Review 6.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

Review 7.  Brain insulin signalling in metabolic homeostasis and disease.

Authors:  Thomas Scherer; Kenichi Sakamoto; Christoph Buettner
Journal:  Nat Rev Endocrinol       Date:  2021-06-09       Impact factor: 43.330

Review 8.  Brain insulin signaling and Alzheimer's disease: current evidence and future directions.

Authors:  Helgi B Schiöth; Suzanne Craft; Samantha J Brooks; William H Frey; Christian Benedict
Journal:  Mol Neurobiol       Date:  2011-12-29       Impact factor: 5.590

9.  Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women.

Authors:  Manfred Hallschmid; Suzanne Higgs; Matthias Thienel; Volker Ott; Hendrik Lehnert
Journal:  Diabetes       Date:  2012-02-16       Impact factor: 9.461

10.  Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.

Authors:  Manfred Hallschmid; Kamila Jauch-Chara; Oliver Korn; Matthias Mölle; Björn Rasch; Jan Born; Bernd Schultes; Werner Kern
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.